[31st March 2018] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include publication of the S-SANOC planning meeting,Tumor Treating Fields (TTFields) now recommended on the guidelines…
[17th March 2018] In healthcare, inefficiency is often caused by neglecting to focus on what matters most to patients. A new international patient survey is gathering insights on inefficiencies in cancer care…
[13th March 2018] New treatment options and effective precision medicine therapies are urgently required for glioblastomas (GBMs), a highly malignant and aggressive type of brain tumour…
[28th February 2018] The IBTA’s monthly e-News has now been released and has been emailed to all subscribers. Some of the highlights from the February issue include research showing that the sickle cell disease drug hydroxyurea may boost chemotherapy…
[20th November 2017] IBTA co-director Kathy Oliver has co-authored a recent article published in the journal Health Expectations which argues that ‘value frameworks’ used to inform treatment decisions should focus on the outcomes that matter most to patients…
[26th August 2017] It has been announced that IBTA’s founding Co-Director and Chair Kathy Oliver will be one of the speakers at the All.Can initiative’s workshop at the European Health Forum Gastein: ‘Making cancer care more efficient – what role can different stakeholders play?’
Like us on Facebook and follow us on Twitter.
The IBTA is a not-for-profit, limited liability company incorporated in England and Wales, Company Number: 6031485. © copyright 2007 - 2014 The International Brain Tumour Alliance [IBTA]. All Rights Reserved. Design by Feelingpeaky
Sitemap | Company information | Disclaimer | Privacy Policy | Cookies Website Photo Credits
